Liver diseases: The enemy with an accomplice ,,,,,,
Some diseases are typical to a period. The previous decades have show... The scientists have been investigating 49 fatal cases of hepatoce...In some cases the disease was caused by the virus of hepatitis B; ...
Some diseases are typical to a period. The previous decades have shown a spurt of diseases like chronic viral hepatitis and liver cancer. Death toll due to these diseases have steadily risen. With figures soaring above the estimated limits, and with scientists finding a new association between these two diseases that affect the liver, a new awareness has been created among the researchers. For several years researchers have been studying hepatocellular cancer cases and have found that all the patients were suffering from a heavy form// of chronic hepatitis.
The scientists have been investigating 49 fatal cases of hepatocellular cancer and therefore it turned out to be possible to conduct not only inter vivos but also pathologoanatomic investigations. The patients' case histories say that some time in the past each of them had an intrusion into circulatory system: these persons had either been donors, or had been operated on, subjected to blood transfusion or intravenous injections. Under a microscope their liver looked as it should look like in case of a sluggish chronic viral hepatitis. However, 65% of the patients got to know that they are ill with hepatitis only during their last hospitalization. In two cases this diagnosis was made posthumously.
In some cases the disease was caused by the virus of hepatitis B; there have also been cases when there was a combination of both viruses. Sometimes physicians were unable to define the virus although the viral nature of hepatitis was undoubted. This probably testifies to the fact that we do not know yet all the viruses that affect liver. Having defined the virus, the physicians found out how it is distributed in the liver. It appeared that the virus of hepatitis B is present mainly in the liver tissue whereas the virus of hepatitis C was present in tumor cells in large quantities. Evidently, the mechanisms of their destructive effect are different; the patients though do not need to go deeply int
'"/>Page: 1 2 Related medicine news :1.
Blood Cells Capable of Regenerating Liver
2.
Liver donors can thrive after transplant3.
Heavy Drinking Raises Risk of Liver Cancer4.
Arthritis Drug May Cause Liver Damage5.
Liver transplant oversight urged6.
Liver key to extending life7.
Liver cancers which spread are linked to a particular gene8.
Troubled Childhood found to affect your Liver9.
New Liver Tumor Treatment10.
Transplants Help Liver Cancer Patients11.
Steroid-Free Liver Transplants
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2...in women years in advance of a medical diagnosis o...demiologists at the University at Buffalo in New Y...for diabetes found in the blood, such as markers o...-acute inflammation and blood clotting factors, ar...
... diet pill under the brand name Alli, there has be...ng down their weight. Alli has been given the stat...s drug is said to block the absorption of fat by t...se stools are reported to be the side effects of A...
... found to bring down the androgen levels in women....emirel University in Isparta, Turkey. Hirsutism i...excessive hair in the face, breasts and stomach in...ed level of male hormone, androgen which is respon...
...death of 16 persons who were infected by the bacte... at a hospital near Montreal .An investigation las...orely missing at the hospital, where even three in...re a single bed. The bacteria C. difficile has be...
Other Medicine News:Health News:Diabetes Risk Factors Develop Earlier in Women Than Men 2(Date:9/3/2008)...BURG, Md., Sept. 3 /- Panacea Pharmac.... Patent Number 7,413,737 covering,antibodies agai...(HAAH), a,proprietary human cancer biomarker and t... in collaboration with the Massachusetts Institute...rldwide rights to this patent,for development of h...
(Date:9/3/2008)... Company to Discuss Phase 3 Plans with FDA, P...apeutics, Inc.,announced today that it successful...pment of the company,s new, innovative low-dose, o... refers to by its internal product,code AG-200-15....ly met its,primary endpoint of ovulation suppressi...
(Date:9/3/2008)...cal Trial Reconfirms Strong Evidence Pycnogenol(R)...g Effect on Joints Following Cessation ...ept. 3 /- According to the Center for...ommon type of arthritis,is on the rise. A new stu...,Research, reveals Pycnogenol(R), bark extract fro...
(Date:9/3/2008)...Germany, Sept. 3 /- A sub-a...d that treatment with prasugrel,compared with clop...ecurrent heart attacks (7.4 percent vs. 9.7 percen...urred around the time of an artery-opening,procedu...I), or if they,occurred spontaneously during the l...
Breaking Medicine Technology:Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6PRA International Announces New Office Opening in Mumbai 14728 1PRA International Announces New Office Opening in Mumbai 14728 2Food insecurity linked with HIV AIDS in Africa 14725 1Food insecurity linked with HIV AIDS in Africa 14725 2Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 1Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 2Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 3Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 1Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 2Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 3Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 4...CISCO, March 19, 2007 /PRNewswire-FirstCall/ --,Me...lts from its,randomized, double-blinded, placebo-c... patients with mild-to-moderate Alzheimer,s,diseas...were,significantly improved compared to patients t...ed, which assessed cognitive function,memory, abi...
... HEIGHTS, N.J.--(BUSINESS WIRE)--Mar 19, 2007 - Ny...y announced positive,results from its newly comple...prostatic hyperplasia (BPH). 26 clinical trial sit...ticipated in the,blinded, placebo controlled study... outcome 8-19,months after NX-1207 treatment. Over...
Other Medicine Technology:Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 2Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 3Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 4Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 2Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 3Inquire
...lly inspects your equipment upon arrival. Our tech...d provides you with a thorough customer quote. We ...get so well help you prioritize repairs. With cust...., , ISI uses only OEM or widely approved equi...
The Infinity™ ALT single liquid stable reagent is intended for the in vitro quantitative determination of ALT in serum. , Infinity™ ALT reagent patented formulation not only provides ex
...owder reagent is intended for the in vitro quantit...ALT (GPT) powder reagent patented formulation not ...ed and convenience, but ensures excellent precisio...gent is suitable for manual use or on automated cl...
Medicine Products: